State Street Corp Edwards Lifesciences Corp Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, State Street Corp holds 26,265,633 shares of EW stock, worth $1.98 Billion. This represents 0.07% of its overall portfolio holdings.

Number of Shares

26,265,633

Previous 26,009,095 0.99%

Holding current value

$1.98 Billion

Previous $2.4 Billion 27.85%

% of portfolio

0.07%

Previous 0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $15.3 Million - $24.1 Million	256,538 Added 0.99%	26,265,633 $1.73 Billion
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $64.6 Million - $72.3 Million	-766,690 Reduced 2.86%	26,009,095 $2.4 Billion
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $13 Million - $17.2 Million	-179,865 Reduced 0.67%	26,775,785 $2.56 Billion
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $31.3 Million - $39.5 Million	507,914 Added 1.92%	26,955,650 $2.06 Billion
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $42 Million - $56.5 Million	-605,568 Reduced 2.24%	26,447,736 $1.83 Billion
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $8.8 Million - $10.2 Million	108,102 Added 0.4%	27,053,304 $2.55 Billion
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $26.4 Million - $30.1 Million	-355,964 Reduced 1.3%	26,945,202 $2.23 Billion
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $33.7 Million - $43.2 Million	493,844 Added 1.84%	27,301,166 $2.04 Billion
Q3 2022 Nov 15, 2022	SELL	$82.37 - $107.29 $7.48 Million - $9.74 Million	-90,807 Reduced 0.34%	26,807,322 $2.22 Billion
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $2.05 Million - $3.03 Million	-23,657 Reduced 0.09%	26,898,129 $2.56 Billion
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $109,403 - $137,708	1,073 Added 0.0%	26,921,786 $3.17 Billion
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $101 Million - $124 Million	948,638 Added 3.65%	26,920,713 $3.49 Billion
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $26 Million - $31 Million	252,381 Added 0.98%	25,972,075 $2.94 Billion
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $603,396 - $753,957	-7,197 Reduced 0.03%	25,719,694 $2.66 Billion
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $10.6 Million - $12.2 Million	-134,815 Reduced 0.52%	25,726,891 $2.15 Billion
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $64 Million - $81.5 Million	-893,253 Reduced 3.34%	25,861,706 $2.36 Billion
Q3 2020 Nov 10, 2020	SELL	$67.19 - $87.44 $33.1 Million - $43.1 Million	-493,061 Reduced 1.81%	26,754,959 $2.14 Billion
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.05 Billion - $1.4 Billion	18,249,113 Added 202.79%	27,248,020 $1.88 Billion
Q1 2020 May 11, 2020	BUY	$52.41 - $81.0 $472 Million - $729 Million	8,998,907 New	8,998,907 $1.7 Billion

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Edwards Lifesciences Corp Transaction History